Ihre E-Mail wurde erfolgreich gesendet. Bitte prüfen Sie Ihren Maileingang.

Leider ist ein Fehler beim E-Mail-Versand aufgetreten. Bitte versuchen Sie es erneut.

Vorgang fortführen?

Exportieren
  • 1
    In: Immunology, Wiley, Vol. 94, No. 2 ( 1998-06-14), p. 213-220
    Kurzfassung: Cyclosporin A reduces the mitotic activity of allosensitized lymphocytes, but fails to limit emigration of these cells into the donor organ. However, the modulation of both lymphocyte proliferation and infiltration are desirable characteristics of immunosuppressive therapy. The calcium‐channel blocker, verapamil, has recently been shown to effectively prevent the transmigration of CD4 + and CD8 + T cells through allogeneic endothelium. Mibefradil (Ro 40‐5967) represents a new generation of calcium antagonists with high potency and long‐term activity. To evaluate the immunosuppressive potential of this drug, the influence of mibefradil on lymphocyte adhesion to, horizontal locomotion along, and penetration through allogeneic endothelium (HUVEC) was performed. When lymphocytes were prestimulated for 24 hr with mibefradil, adhesion and penetration were dose‐dependently reduced. The adhesion ID 50 values were 3·4 μm (CD4 + T cells) versus 9·2 μm (CD8 + T cells) and 2·1 μm (CD4 + T cells) versus 3·9 μm (CD8 + T cells) with regard to penetration. Mibefradil also effectively blocked horizontal locomotion. Specific down‐regulation of T‐cell binding to the P‐selectin receptor (ID 50 : CD4 + T cells, 0·8 μm; CD8 + T cells, 1·2 μm) and to the intracellular adhesion molecule‐1 (ICAM‐1) receptor (ID 50 : CD4 + T cells, 1·9 μm; CD8 + T cells, 1·5 μm) by mibefradil seems to be responsible for the decreased adhesion and penetration rates. Reduction of intracellular F‐actin in T lymphocytes could diminish cell locomotion. In conclusion, the potent suppressive properties of mibefradil support its use as a co‐medication in cyclosporin A‐based immunosuppressive therapy. CsA, cyclosporin A
HUVEC, human umbilical vein endothelial cells
ICAM‐1, intercellular adhesion molecule‐1
LFA‐1, leukocyte function‐associated antigen‐1
PBL, peripheral blood lymphocytes
PSGL‐1, P‐selectin glycoprotein ligand‐1.
    Materialart: Online-Ressource
    ISSN: 0019-2805 , 1365-2567
    RVK:
    Sprache: Englisch
    Verlag: Wiley
    Publikationsdatum: 1998
    ZDB Id: 2006481-0
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
Schließen ⊗
Diese Webseite nutzt Cookies und das Analyse-Tool Matomo. Weitere Informationen finden Sie auf den KOBV Seiten zum Datenschutz